Cargando…

Arsenic Trioxide in Synergy with Vitamin D Rescues the Defective VDR-PPAR-γ Functional Module of Autophagy in Rheumatoid Arthritis

Dysregulated autophagy leads to autoimmune diseases including rheumatoid arthritis (RA). Arsenic trioxide (ATO) is a single agent used for the treatment of acute promyelocytic leukemia and is highly promising for other malignancies but is also attractive for RA, although its relationship with autoph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Weiyan, Li, Chunling, Zhang, Zhiyi, Zhang, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530228/ https://www.ncbi.nlm.nih.gov/pubmed/31205465 http://dx.doi.org/10.1155/2019/6403504

Ejemplares similares

Data on arsenic trioxide modulates Treg/Th17/Th1/Th2 cells in treatment-naïve rheumatoid arthritis patients and collagen-induced arthritis model mice
por: Li, Chunling, et al.
Publicado: (2019)

Inhibition of angiogenesis by arsenic trioxide via TSP-1–TGF-β1-CTGF–VEGF functional module in rheumatoid arthritis
por: Zhang, Juan, et al.
Publicado: (2017)

Single Cell RNA-Seq Analysis Identifies Differentially Expressed Genes of Treg Cell in Early Treatment-Naive Rheumatoid Arthritis By Arsenic Trioxide
por: Li, Chunling, et al.
Publicado: (2021)

Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells in vitro
por: Kouhpaikar, Hamideh, et al.
Publicado: (2020)

Establishment and characterization of arsenic trioxide resistant KB/ATO cells
por: Zhang, Yun-Kai, et al.
Publicado: (2017)

Angiogenesis is Inhibited by Arsenic Trioxide Through Downregulation of the CircHIPK3/miR-149-5p/FOXO1/VEGF Functional Module in Rheumatoid Arthritis
por: Zhang, Juan, et al.
Publicado: (2021)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022)

Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy
por: Li, Tao, et al.
Publicado: (2018)

Melatonin enhances arsenic trioxide-induced cytotoxicity by modulating autophagy in an acute promyelocytic leukemia cell line
por: Wei, Xia, et al.
Publicado: (2019)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells
por: Tai, Sheng, et al.
Publicado: (2017)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines
por: Mohammadi Kian, Mahnaz, et al.
Publicado: (2020)

Effects of Sorafenib and Arsenic Trioxide on U937 and KG-1 Cell Lines: Apoptosis or Autophagy?
por: Haghi, Atousa, et al.
Publicado: (2020)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013)

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats
por: Zhang, Weiqian, et al.
Publicado: (2014)

Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy
por: Song, Zhixia, et al.
Publicado: (2021)

Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells
por: Ahmad, Iman M., et al.
Publicado: (2023)

Vitamin D and VDR Gene Polymorphisms’ Association with Rheumatoid Arthritis in Lithuanian Population
por: Punceviciene, Egle, et al.
Publicado: (2021)

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
por: Varghese, Mathews V., et al.
Publicado: (2013)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018)

QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
por: Zeitjian, Vicken, et al.
Publicado: (2019)

PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
por: Corona, Juan Carlos, et al.
Publicado: (2016)

Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway
por: Li, Aimei, et al.
Publicado: (2021)

Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis
por: Zhang, Yong, et al.
Publicado: (2016)

Arsenic trioxide as a novel anti-glioma drug: a review
por: Fang, Yi, et al.
Publicado: (2020)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway
por: Fang, Shaohong, et al.
Publicado: (2021)

Broad-spectrum rescue compounds for structural p53 mutations: perspective on ‘Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site’
por: Wu, Jia-Le, et al.
Publicado: (2021)

RF15 | PMON293 Metabolic activation of tachysterol to biologically active hydroxyderivatives that act on VDR, AhR, LXRs and PPARγ receptors
por: Slominski, Andrzej, et al.
Publicado: (2022)

Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
por: Yu, Mengzhen, et al.
Publicado: (2022)

Dual effects of arsenic trioxide on tumor cells and the potential underlying mechanisms
por: Zhang, Xiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_90octvm5ermrl1e75fnae88dte